NCT00192855View on ClinicalTrials.gov

Entacapone Augmentation for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Entacapone

Entacapone 600mg BID

Trial Locations (1)

31096

Rambam medical center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT00192855 - Entacapone Augmentation for Schizophrenia | Biotech Hunter | Biotech Hunter